• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项前瞻性研究,评估青光眼患者从使用含防腐剂的前列腺素眼药水治疗转换为使用无防腐剂他氟前列素后的眼压变化。

A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients.

作者信息

Ranno Stefano, Sacchi Matteo, Brancato Cinzia, Gilardi Daniela, Lembo Andrea, Nucci Paolo

机构信息

Eye Clinic, San Giuseppe Hospital, University of Milan, Via San Vittore 12, Milan, Italy.

出版信息

ScientificWorldJournal. 2012;2012:804730. doi: 10.1100/2012/804730. Epub 2012 Apr 19.

DOI:10.1100/2012/804730
PMID:22606063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3346840/
Abstract

PURPOSE

To compare the ocular hypotensive effect of tafluprost with prostaglandin analogues (PGAs) in glaucoma patients.

METHODS

89 primary open-angle glaucoma patients treated with bimatoprost, latanoprost, or travoprost for at least 3 months complaining for ocular discomfort were switched to tafluprost. IOP was assessed at baseline and 3 months after switching the therapy by daily curve. Primary outcome was to compare the mean daily IOP of tafluprost with PGAs.

RESULTS

The mean daily IOP was 16 ± 2.1 and 16.6 ± 2.0 mm Hg at baseline and after switching to tafluprost, respectively (P > 0.05). When analysis was carried out between tafluprost and each previous PGAs, the comparison between latanoprost and tafluprost and travoprost and tafluprost did not show any statistically significant difference in mean daily IOP and at each time point. The comparison between bimatoprost and tafluprost showed a statistically significant difference in mean daily IOP (P < 0.05) and at each time point (P < 0.05).

CONCLUSIONS

After 3 months of switching tafluprost showed an overall IOP lowering effect similar to others PGAs. When each PGA was compared with tafluprost, bimatoprost showed to provide a statistically significant additional IOP lowering effect.

摘要

目的

比较他氟前列素与前列腺素类似物(PGAs)在青光眼患者中的降眼压效果。

方法

89例接受比马前列素、拉坦前列素或曲伏前列素治疗至少3个月且抱怨眼部不适的原发性开角型青光眼患者改用他氟前列素。在基线期以及换药3个月后通过每日眼压曲线评估眼压。主要结局是比较他氟前列素与PGAs的平均每日眼压。

结果

基线期和改用他氟前列素后,平均每日眼压分别为16±2.1和16.6±2.0 mmHg(P>0.05)。当对他氟前列素与每种先前使用的PGAs进行分析时,拉坦前列素与他氟前列素之间以及曲伏前列素与他氟前列素之间在平均每日眼压及各个时间点的比较均未显示出任何统计学上的显著差异。比马前列素与他氟前列素之间的比较在平均每日眼压方面(P<0.05)以及各个时间点(P<0.05)均显示出统计学上的显著差异。

结论

改用他氟前列素3个月后,其总体降眼压效果与其他PGAs相似。当将每种PGAs与他氟前列素进行比较时,比马前列素显示出具有统计学意义的额外降眼压效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/3346840/fadef0f7cc5f/TSWJ2012-804730.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/3346840/8d503da7ce0b/TSWJ2012-804730.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/3346840/fadef0f7cc5f/TSWJ2012-804730.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/3346840/8d503da7ce0b/TSWJ2012-804730.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/3346840/fadef0f7cc5f/TSWJ2012-804730.002.jpg

相似文献

1
A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients.一项前瞻性研究,评估青光眼患者从使用含防腐剂的前列腺素眼药水治疗转换为使用无防腐剂他氟前列素后的眼压变化。
ScientificWorldJournal. 2012;2012:804730. doi: 10.1100/2012/804730. Epub 2012 Apr 19.
2
Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.局部用前列腺素类似物治疗原发性开角型青光眼和高眼压症的疗效及耐受性比较
Ann Pharmacother. 2014 Dec;48(12):1585-93. doi: 10.1177/1060028014548569. Epub 2014 Sep 2.
3
Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.前列腺素类似物与小鼠眼压:考虑24小时眼压变化,探讨他氟前列素、拉坦前列素、曲伏前列素和乌诺前列酮的作用
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2006-11. doi: 10.1167/iovs.04-1527.
4
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.从 VISIONARY 研究的基线单药治疗数据来看,改用不含防腐剂的他氟前列素/噻吗洛尔固定剂量组合治疗开角型青光眼或高眼压症:亚组分析。
Adv Ther. 2022 Aug;39(8):3501-3521. doi: 10.1007/s12325-022-02166-6. Epub 2022 May 7.
5
[Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma].[三种前列腺素滴眼液对开角型青光眼眼压降低效果的比较]
Zhonghua Yan Ke Za Zhi. 2011 Feb;47(2):109-13.
6
Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.四种前列腺素类似物双侧治疗健康受试者的疗效比较。
Jpn J Ophthalmol. 2012 Jul;56(4):346-53. doi: 10.1007/s10384-012-0155-2. Epub 2012 Jun 7.
7
Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.比较曲伏前列素和贝美前列素加噻吗洛尔固定组合在以前用拉坦前列素加噻吗洛尔固定组合治疗的开角型青光眼患者中的疗效。
Am J Ophthalmol. 2010 Oct;150(4):575-80. doi: 10.1016/j.ajo.2010.05.003. Epub 2010 Aug 4.
8
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.拉坦前列素、比马前列素和曲伏前列素治疗眼压升高患者的比较:一项为期12周的随机、盲法评估者多中心研究。
Am J Ophthalmol. 2003 May;135(5):688-703. doi: 10.1016/s0002-9394(03)00098-9.
9
Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study.在先前使用拉坦前列素的患者中,比马前列素与曲伏前列素的疗效和耐受性:一项为期 3 个月、随机、盲法评估、多中心研究。
Br J Ophthalmol. 2010 Jan;94(1):74-9. doi: 10.1136/bjo.2009.158071. Epub 2009 Sep 1.
10
The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.拉坦前列素、比马前列素和曲伏前列素对开角型青光眼患者眼压昼夜变化的影响。
J Glaucoma. 2008 Jan-Feb;17(1):36-9. doi: 10.1097/IJG.0b013e318133fb70.

引用本文的文献

1
From Eye Care to Hair Growth: Bimatoprost.从眼部护理到头发生长:比马前列素。
Pharmaceuticals (Basel). 2024 Apr 27;17(5):561. doi: 10.3390/ph17050561.
2
A Pooled Assessment of Ocular Surface Disease After Switching from Preserved Prostaglandins to Tafluprost Across Six Countries in Asia.一项在亚洲六个国家中从使用防腐剂的前列腺素转换为他氟前列素后眼表疾病的汇总评估。
Clin Ophthalmol. 2022 Aug 17;16:2669-2676. doi: 10.2147/OPTH.S372312. eCollection 2022.
3
Inter-Eye Comparison of the Ocular Surface of Glaucoma Patients Receiving Surgical and Medical Treatments.

本文引用的文献

1
Risk factors for visual field progression in the groningen longitudinal glaucoma study: a comparison of different statistical approaches.格罗宁根纵向青光眼研究中视野进展的风险因素:不同统计方法的比较。
J Glaucoma. 2012 Dec;21(9):579-85. doi: 10.1097/IJG.0b013e31822543e0.
2
Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension.与0.0015%他氟前列素相比,0.004%曲伏前列素对原发性开角型青光眼或高眼压症患者的日间降眼压疗效及安全性。
Clin Ophthalmol. 2010 Dec 8;4:1459-63. doi: 10.2147/OPTH.S13720.
3
Twenty-four-hour ocular hypotensive effects of 0.0015% tafluprost and 0.005% latanoprost in healthy subjects.
接受手术和药物治疗的青光眼患者眼表的双眼比较
J Clin Med. 2022 Feb 24;11(5):1238. doi: 10.3390/jcm11051238.
4
Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.从贝美前列素-噻吗洛尔转换为他氟前列素-噻吗洛尔滴眼液的患者的眼部体征和症状变化:一项开放性 IV 期研究。
BMJ Open. 2019 Apr 2;9(4):e024129. doi: 10.1136/bmjopen-2018-024129.
5
Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma.全身性抗高血压药物对原发性开角型青光眼患者开始局部使用前列腺素后眼压变化的影响。
Clin Ophthalmol. 2019 Jan 23;13:207-213. doi: 10.2147/OPTH.S192010. eCollection 2019.
6
Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients.比马前列素、拉坦前列素、曲伏前列素和他氟前列素在青光眼患者中的疗效及眼表疾病指数评分比较
J Ophthalmol. 2018 Mar 7;2018:1319628. doi: 10.1155/2018/1319628. eCollection 2018.
7
Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost.无防腐剂他氟前列素在曾用拉坦前列素治疗的正常眼压性青光眼患者中的疗效
Clin Ophthalmol. 2014 Sep 15;8:1855-8. doi: 10.2147/OPTH.S65203. eCollection 2014.
8
Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature.玻璃体内地塞米松植入物治疗前列腺素诱导的难治性人工晶状体性黄斑囊样水肿的疗效:病例报告及文献复习
Clin Ophthalmol. 2014 Jul 2;8:1253-7. doi: 10.2147/OPTH.S63829. eCollection 2014.
9
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial.0.03% 无防腐剂贝美前列素滴眼液对比 0.03% 贝美前列素滴眼液(卢美根)治疗青光眼或高眼压症:一项为期 12 周、随机、双盲的试验。
Br J Ophthalmol. 2013 Aug;97(8):989-93. doi: 10.1136/bjophthalmol-2012-303040. Epub 2013 Jun 6.
10
Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma.他氟前列素每日一次用于治疗开角型青光眼患者的眼压升高。
Clin Ophthalmol. 2013;7:7-14. doi: 10.2147/OPTH.S30951. Epub 2012 Dec 21.
健康受试者中 0.0015%他氟前列素和 0.005%拉坦前列素的 24 小时降眼压作用。
Jpn J Ophthalmol. 2010 Jul;54(4):286-90. doi: 10.1007/s10384-010-0828-7. Epub 2010 Aug 11.
4
Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.比较曲伏前列素和贝美前列素加噻吗洛尔固定组合在以前用拉坦前列素加噻吗洛尔固定组合治疗的开角型青光眼患者中的疗效。
Am J Ophthalmol. 2010 Oct;150(4):575-80. doi: 10.1016/j.ajo.2010.05.003. Epub 2010 Aug 4.
5
IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.在患有眼高压或青光眼的患者中,无防腐剂他氟前列素 0.0015% 的降眼压效果和耐受性。
Curr Med Res Opin. 2010 Aug;26(8):1905-13. doi: 10.1185/03007995.2010.492030.
6
Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.从含防腐剂的前列腺素制剂转换为不含防腐剂的前列腺素制剂在局部青光眼药物治疗中的应用。
Acta Ophthalmol. 2010 May;88(3):329-36. doi: 10.1111/j.1755-3768.2010.01907.x.
7
Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study.他氟前列素 0.0015%滴眼液与拉坦前列素 0.005%滴眼液治疗开角型青光眼和高眼压症的疗效和安全性:一项随机、双盲、III 期研究的 24 个月结果。
Acta Ophthalmol. 2010 Feb;88(1):12-9. doi: 10.1111/j.1755-3768.2010.01862.x.
8
Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension.他氟前列素降低开角型青光眼和高眼压症患者眼压升高的临床评估
Clin Ophthalmol. 2010 Mar 24;4:163-70. doi: 10.2147/opth.s6368.
9
A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost.一项关于他氟前列素与拉坦前列素相比降眼压作用的持续时间和稳定性以及耐受性的 II 期研究。
J Ocul Pharmacol Ther. 2010 Feb;26(1):97-104. doi: 10.1089/jop.2009.0066.
10
Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells.细胞流式术评估局部青光眼药物对人眼上皮角膜细胞的细胞抑制和细胞毒性作用。
Cytometry B Clin Cytom. 2010 Mar;78(2):130-7. doi: 10.1002/cyto.b.20493.